Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Curriculum Vitae Jennifer K. (Kristie) Johnson, Ph.D., D (ABMM) Associate Professor, Department of Pathology University of Maryland School of Medicine Date October 7, 2016 Contact Information Business Address: Office Phone Number: Laboratory Phone Number: Fax: Beeper: Email: Education 1992-1996 1996-2002 1998-2000 22 South Greene Street, Room N2W50B Baltimore, Maryland 21201 (410) 328-6698 (410) 706-7062 (410) 706-8414 (410) 382-2337 x3977 [email protected] B.S. Degree in Biology, minor in Chemistry, Salisbury State University Salisbury, Maryland Ph.D. in Microbiology and Immunology, University of Maryland, Baltimore Thesis: Analysis of the Specificity and Genetics of Antibodies to Soman. Mentor: David E. Lenz, Ph.D. Rapid Transition Training Program, Categorical in Microbiology University of Maryland School of Medicine Department of Medical and Research Technology Postgraduate Education and Training 2003-2006 Postdoctoral Fellowship, Department of Pathology, University of Maryland School of Medicine Mentor: Richard A. Venezia, Ph.D., D(ABMM) Certifications 1998-Present Technologist in Microbiology, American Society of Clinical Pathology Board of Certification 2010-Present Diplomate in Public Health and Medical Microbiology, The American Board of Medical Microbiology of the American Academy of Microbiology Employment History Academic Appointments 2006-2012 Assistant Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment) 2007-Present VA Research Health Scientist (WOC), Baltimore Veterans Administration 2011-2012 Assistant Professor, Department of Epidemiology and Public Health University of Maryland School of Medicine (Secondary appointment) JKJohnson 2012-Present Associate Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment) 2012-Present Associate Professor, Department of Epidemiology and Public Health University of Maryland School of Medicine (Secondary appointment) 2013-Present Associate Professor, Department of Microbiology and Immunology University of Maryland School of Medicine (Secondary appointment) Other Employment 1996-1997 ORISE Fellow, Toxicology Division, Toxicology Evaluation Branch US Army Center for Health Promotion and Preventive Medicine Aberdeen Proving Ground-Edgewood Area, Maryland 21010 1998 Graduate Research Assistant, Department of Oral and Craniofacial Sciences School of Dentistry University of Maryland, Baltimore 1998-2002 ORISE Fellow, Pharmacology Division, Biochemical Pharmacology Branch US Army Medical Research Institute of Chemical Defense Aberdeen Proving Ground-Edgewood Area, Maryland 21010 2003 Scientist - Section Head Rapid Diagnostics: Bioterrorism Response Section Maryland Department of Health and Mental Hygiene Professional Society Memberships 1997-Present National and Maryland Branch of American Society of Microbiology 2006-Present Pan American Society of Clinical Virology 2008-Present Association of Molecular Pathology 2013-Present Society of Healthcare Epidemiology Honors and Awards 1999 Excellence in Microbiology Award, University of Maryland School of Medicine Department of Medical and Research Technology 2000-2001 Merit Scholarship Award, University of Maryland Dental School 2000-2002 NIH National Research Service Award Training Program 2011 Richard S. Schwalbe Award, American Society of Microbiology, Maryland Branch Clinical Activities 2006-2014 Associate Director of Clinical Microbiology and Virology Laboratories Laboratories of Pathology, University of Maryland Medical Center Clinical Microbiology Seminar Series Pace Lectures for Laboratory Staff Physician Consults Patient Rounds Clinical Plate Rounds Member o Pandemic Steering Committee o Executive Infection Control Committee Page 2 JKJohnson o Antimicrobial Subcommittee o Ebola Steering Committee Moved all protocols to electronic and placed on share drive for all employees to view while working at the bench. Molecular Detection o MRSA o Influenza and RSV o Respiratory viruses (10) o Enterovirus o Clostridium difficile o PNA-FISH from positive blood cultures Surveillance o MRSA o Acinetobacter baumannii o Carbapenem-Resistant Enterobacteriaceae Rapid Detection from Blood Cultures Antibiotic Resistance o Fluconazole susceptibility in Candida species o Carbapenemase detection in Enterobacteriaceae 2014-2015 Interim Director of Clinical Microbiology and Virology Laboratories. Laboratories of Pathology, University of Maryland Medical Center 2014-2015 Interim Director of Clinical Microbiology, University of Maryland Pathology Associates 2014-Present Co-Director of Bio-containment Unit, Laboratory, University of Maryland Medical Center 2015-Present Director of Clinical Microbiology, University of Maryland Medical Center 2015-Present Director of Clinical Microbiology, University of Maryland Pathology Associates Administrative Service Institutional Service 2006-2014 Associate Director of Clinical Microbiology and Virology Laboratories Laboratories of Pathology, University of Maryland Medical Center 2006-Present Member, UMMC Infection Control Executive Committee 2008-2010 Associate Member, Graduate Faculty 2009-Present Member, UMMC Pandemic Steering Committee 2010-Present Regular Member, Graduate Faculty 2011-Present Member, Host Defenses and Infectious Diseases Committee, University of Maryland School of Medicine 2011-Present Interviewer, Office of Admissions, University of Maryland School of Medicine 2011-Present Member, UMMC Antimicrobial Subcommittee of the P&T Committee 2011-Present Member, Pathology Residency Committee 2011 Judge, Medical Student Research Day 2013-Present Member, Clinical Competency Committee, Department of Pathology 2014-2015 Interim Director of Clinical Microbiology and Virology Laboratories Page 3 JKJohnson 2014-2015 2014-Present 2014-Present 2014-Present 2015-Present 2015-Present 2016-Present 2015-Present 2015-Present Laboratories of Pathology, University of Maryland Medical Center Interim Director of Clinical Microbiology, University of Maryland Pathology Associates Member, UMMC Strategic Steering Committee-Ebola Preparation Plan Member, UMMC Laboratory Services Committee-Ebola Preparation Plan Co-Director of Bio-containment Unit, Laboratory, University of Maryland Medical Center Member, Quality Assurance Oversight Committee, University of Maryland Medical Center, Laboratories of Pathology Member, Institutional BioSafety Committee, University of Maryland, Baltimore Member, UMMC Laboratory Utilization Committee Director of Clinical Microbiology, University of Maryland Medical Center Director of Clinical Microbiology, University of Maryland Pathology Associates Local Service 2009 Member of ASM Division C Chair nomination Committee 2010-2014 Judge for J. Howard Brown Award given by the Maryland Branch ASM 2010-Present Member, Maryland MDRO Collaborative 2011-2014 Board of Directors, American Society of Microbiology, Maryland Branch 2012-2013 President, American Society of Microbiology, Maryland Branch National Service 2008-Present Reviewer, Diagnostic Microbiology and Infectious Diseases (1x/year) 2010-Present Reviewer, European Journal of Clinical Microbiology and Infectious Diseases(1x/year) 2011-Present Reviewer, Journal of Medical Microbiology (1x/year) 2011-Present Reviewer, Journal of Clinical Microbiology (3x/year) 2011-Present Reviewer, Journal of Microbiological Methods (0-1x/year) 2011-Present Reviewer, American Journal of Infection Control (0-1x/year) 2012-Present Reviewer, PLOS ONE (2x/year) 2012-Present Member, Clinical Microbiology Mentoring Committee of the Professional Practice Committee, American Society of Microbiology (Term until 2017) 2012-2014 Member, The American Board of Medical Microbiology (ABMM) Validation Committee 2012 American Society of Microbiology Career Session (June 16, 2012) 2012-Present Reviewer, Infections (0-1x/year) 2012-Present Reviewer, Journal of Antimicrobial Chemotherapy (1x/year) 2014-Present American Society of Microbiology Division C Finance Committee 2014 Member, Expert Panel, UPMC Center for Health Security, Improving the Odds: What government can do to encourage the development of commercially viable infectious disease diagnostics. 2014-Present Member, The American Board of Medical Microbiology (ABMM) Item Committee 2014 American Society of Microbiology Convener for Diagnostic Microbiology and Epidemiology Session for the 114th General Meeting May 18, 2014: The Evolving Page 4 JKJohnson 2014-Present 2015-Present 2015-Present 2016-Present 2016-Present 2016-Present 2016 2016 2016 2016-present 2016-present Role on Active Surveillance for MDROs for Infection Prevention: The Impact of New Landmark Studies upon the Clinical Microbiologist. Reviewer, Annals of Clinical Microbiology and Antimicrobials (0-1x/year) Member, Editorial Board, Journal of Clinical Microbiology (2017) Member, Methods Application and Interpretation Working Group for the Subcommittee on Antimicrobial Susceptibility Testing, Clinical Laboratory Standards Institute (CLSI) Member, Editorial Board, Journal of Applied Laboratory Medicine (2019) Reviewer, Journal of Applied Laboratory Medicine (2x/year) Member, Carbapenemase Inactivation Method Working Group, Clinical laboratory Standards Institute (CLSI) American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 18, 2016: Guess the Bacterial Resistance Mechanism American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 19, 2016: Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care Study Section Member, Defense Medical Research and Development Program Scientific Lead, CDC/ASM Laboratory Medicine Best Practices committee on Bloodstream Infections Member, Association of Public Health Laboratories (APHL) Biosafety and Biosecurity Partners Forum (recently appointed by SHEA) Teaching Service Prior to Faculty Appointment 1998 Laboratory Assistant, Pathogenic Microbiology, 3rd year Medical Technology Students- 6 contact hours/week Department of Medical and Research Technology, University of Maryland School of Medicine 1998 Lecturer Pathogenic Microbiology 3rd year Medical Technology Students- 4 contact hours Department of Medical and Research Technology, University of Maryland School of Medicine 1999-2001 Laboratory Assistant Dental Microbiology 2nd year Dental Students – 1 contact hour/week University of Maryland Dental School Faculty Appointment Basic Sciences 2004-Present Preceptor, Laboratory Small Group Host Defenses and Infectious Diseases Laboratory Second year Medical Students Page 5 JKJohnson 2005-2007 40 students/year, 6 hours/year University of Maryland School of Medicine Lecturer Seminars in Biological Terrorism Smallpox 6-8 students, 2 hours/year Department of Pathology, University of Maryland School of Medicine 2006-Present Member of Thesis/Dissertation Committee Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine 7 graduate students, 20 hours/year per mentee 2007 Lecturer Emerging Infections (NURS 418) Molecular Epidemiology 20 nursing students, 2 hours/year University of Maryland School of Nursing 2007-2013 Research Mentor Molecular Epidemiology Practicum Epidemiology Ph.D. Graduate Students Molecular Epidemiology Track, University of Maryland Graduate School 2 students/ 20 hours 2009-Present Lecturer Clinical Virology (MEDT 471) 15 students, 6 hours/year Department of Medical and Research Technology, University of Maryland School of Medicine 2009-Present Member of Thesis/Dissertation Committee Department of Medical and Research Technology, University of Maryland School of Medicine 1 graduate student, 20 hours/year per mentee 2010 Lecturer Pathogenic Microbiology (MEDT 472) 12 students, 4 hours/year Department of Medical and Research Technology, University of Maryland School of Medicine 2010-Present Primary Mentor Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine 3 graduate students, 104 hours/year per mentee 2011-Present Lecturer, Bacteriology Laboratory I, II, and III Host Defenses and Infectious Diseases Laboratory Second year Medical Students 160 students/year, 6 hours/year University of Maryland School of Medicine Page 6 JKJohnson 2015-Present Lecturer, Principles of Pharmacology University of Maryland, Baltimore School of Medicine Department of Pharmacology 10 graduate students, 6 hours/year Clinical Sciences (Fellows and Residents) 2003-Present Medical Microbiology Plate Rounds Clinical Microbiology Laboratory 1st and 2nd year Infectious Disease Fellows, 3rd or 4th year Medical Students, Pathology Residents and Attendings 12-15 fellows per year, 2-3 medical students, 1 pathology resident, 1-2 faculty members/year 78 contact hours/year Department of Pathology, University of Maryland Medical Center 2006-Present Mentor Medical Microbiology Rotations 5-6 pathology residents, 1-2 medical students 2 hours/ rotation Microbiology Laboratory, University of Maryland Medical Center 2006-Present Medical Microbiology Lectures Pathology Residents 10-12 residents, 8 contact hours Department of Pathology, University of Maryland Medical Center 2014-Present Medical Microbiology Rotations Infectious Disease Fellows 10-12 fellows/year, 10 contact hours Department of Medicine, Division of Infectious Diseases, University of Maryland Medical Center Students/Residents/Fellows Mentored *Indicates that I serve(d) as the primary mentor Training period 2006-2009 Student Mentor Current Position Kristen Kriesel, MS, Ph.D. Ph.D. Student Thesis Committee Member 2007-2008 Kerri Thom, MD, MS Master Student Thesis Committee Member STD MIS Data Manager Virginia State Health Department Assistant Professor, University of Maryland, School of Medicine Page 7 JKJohnson 2007 Simone Shurland, Ph.D Ph.D. Student Laboratory Rotation 2007-2008 Simone Shurland, Ph.D Ph.D. Student Thesis Committee Member Microbiologist, FDA Bethesda, Maryland Microbiologist, FDA Bethesda, Maryland 2007-2009 Marin Schweizer, Ph.D Ph.D. Student Thesis Committee Member Research Associate, University of Iowa, School of Medicine 2009 Albert Lee Ph.D. Student Laboratory Rotation Ph.D. Student, UMB 2009-2010 Anne Koehne de Gonzalez Medical Student 2009 Angela Stancil* Master Student Laboratory Roatation Pathology Resident, Columbia University Medical Center, New York City Biology High School Teacher 2009 Adebola Ajao Ph.D. Student Thesis Committee Member Microbiologist, FDA Bethesda, Maryland 2009 Monica Smith Master Student Thesis Committee Member Becton Dickinson Sparks, MD 2009-2011 Angela Stancil* Master Student Thesis Committee Member Biology High School Teacher 2010 Aaron Hess Medical Student 2010 Jennifer Siu 2010 Marin Schweizer, Ph.D. Medical Student Summer Rotation Research Associate 2011-2012 Aaron Hess Anesthesiology Resident, University of Wisconsin-Madison MD/MPH Student, UMB Research Associate, University of Iowa, School of Medicine Anesthesiology Resident, University of Wisconsin-Madison MD/Ph.D. Student Page 8 JKJohnson 2012-2012 Mallory Boutin* Capstone Mentor 2011-2014 Postdoctoral Fellow 2012-2014 Tracy Hazen, Ph.D. Chris Pepin* 2013-2014 Shana Burrowes 2013-2014 Jackie Bork* 2015-2016 Emily Stucke 2015-2016 2016-Present UM College Park Bio-Engineering Group Eric Kong 2016-Present Sarah Jackson Ph.D. Student Thesis Committee Member Ph.D. Student, UMB 2016-Present Natalia Blanco Herrera, Ph.D. Postdoctoral Fellow Postdoctoral Fellow, UMB Student Laboratory Rotation Student Laboratory Rotation Research Elective Student Laboratory Rotation Clinical Advisor, Student Capstone Project Ph.D. Student Thesis Committee Member Research Associate, University of San Diego UMB Research Associate Ph.D. Student, UMB Ph.D. Student, UMB Clinical Instructor, JHU Ph.D. Student, UMB Bio-Engineering Undergraduate Students Ph.D. Student, UMB Grant Support Active Grants 10/01/11 - 03/31/17 (NCE) 07/01/12 - 12/31/17 (NCE) 04/01/14 - 03/31/16 Role: Co-Investigator (10%) PI: M.C. Roghmann “Metagenomic Studies of MRSA Colonization” Veterans Health Administration CSR&D Total Direct Costs: $508,781 Total Indirect Costs: $0 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Co-Investigator (10%) PI: M.C. Roghmann “Modifying Isolation Precautions for MRSA in Non-acute Care Settings” VA Merit Grant Health Services R&D RII10-154 Total Direct Costs: $1,035,459 Total Indirect Costs: $0 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Co-Investigator (5%) PI: K. Kotloff Page 9 JKJohnson (NCE) 08/01/15 - 07/31/19 09/30/15 - 12/29/16 9/15/15-9/14/17 09/30/15 - 09/29/18 10/01/15-3/31/18 03/01/16-02/28/18 “Incidence, Mode of Transmission, and Sequelae of Community-Acquired Methicillin Resistant Staphylococcus aureus Infection in the Neonatal Intensive Care Unit and the Effectiveness of Decolonization” NIH VTEU Direct Costs: $822,310 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Co-Investigator (5%) PI: Thom Removing barriers to hand hygiene and glove compliance: Evaluation of two novel time-efficient interventions Agency for Healthcare Research and Quality R01 HS024108-01 Direct and Indirect cost: $1,571,807 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Principal Investigator (2%) Sentinel Site Surveillance for AR Organisms II CDC-SHEPheRD Program Contract RFTOP 2015-008 Direct Cost: $78,500 Indirect Cost: $20,500 Role: Co-investigator (10%) PI: Cross Development of a multivalent vaccine to prevent invasive infections and colonization with Klebsiella pneumoniae and Pseudomonas aeruginosa. Nosocimial Vaccine Company Total Direct Costs: $3, 239,933 Provide bacterial strains and expertise in Klebsiella pneumoniae and Pseudomonas aeruginosa. Role: Co-investigator (10%) PI: Harris Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II Centers for Disease Control 1U54CK0000450-01 Direct and Indirect cost: $1,432,368 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Co-investigator (10%) PI: Harris “Does Universal Glove and Gown use decrease carbapenem-resistance Gram-negative bacteria” AHRQ R18 HS024045 Total Directs: $770,800 Total Indirects: $417,310 Direct laboratory work and personnel and review, interpret, analyze, and publish data. Role: Co-Investigator (10%) PI: M.C. Roghmann “Transmission of Antibiotic-resistant Gram-negative Bacteria in Nursing Homes.” Page 10 JKJohnson National Institute of Allergy and Infectious Diseases R03-A1-122223 Total Direct Costs: $153,000 Direct laboratory work and personnel and review, interpret, analyze, and publish data. 09/01/2016-08/31-17 Role: Principal Investigator (2%) “Understanding the workflow of positive blood cultures from sampling to results.” Q-Linea Direct Costs: $9,999 8/10/16-07/31/2020 Role: Co-Investigator (10%) PI: Harris “Epidemiology of CRE and MRSA transmission: patient and organism factors” NIH National Institute of Allergy and Infectious Diseases 1R01AL121146-01 Total Directs: $1,800,599 Direct laboratory work and personnel and review, interpret, analyze, and publish data. 09/15/16-11/14/17 Role: Co-Principal Investigator (10%) “Identification of Microbial disruption indices (MDI) predictive of colonization and dominance by multi-drug resistant Pseudomonas aeruginosa. “ Centers for Disease Control and Prevention BAA 2016-N-17812 Total Costs: $459,721 Total Indirects: $606,837 Pending Grants 10/01/16-09/30/17 04/1/17-03/31/22 Completed Grants 09/01/05 - 07/31/12 Role: Principal Investigator (2%) “A Clinical Evaluation of a Gastrointestinal Infection panel Assay system (ACEGIS)” Applied BioCode Total Cost: $100,000 Role: Sub-award PI (10%) PI: Bachman “Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status” NIH R01 AI 125307 01 A1 NIH-DHHS-US Total Cost: $312,770 sub award Total Cost: $2,713,340 Role: Investigator/Scholar (75%) PI: A.R. Shuldiner “Transmission of Plasmid Mediated AmpC β-lactamases” University of Maryland Multidisciplinary Research Career Development Program (MCRDP) NIH K12RR023250 Page 11 JKJohnson Total Direct Costs: $12,309,704 06/01/07 - 11/01/07 Role: PI (5%) “Culture results for patients with positive blood cultures” AdvanDx Total Direct Costs: $3,000 08/01/07 - 07/31/08 Role: PI (75%) “Understanding Resistance Mechanisms in Fecal Microorganisms” University of Maryland GCRC Total Direct Costs: $10,000 09/30/07 - 09/29/08 Role: Co-Investigator (in kind/mentor) PI: K Kreisel “Risk Factors and Outcomes of Infections Due to USA300 Methicillin Resistant Staphylococcus aureus” CDC R36 Grant for Public Health Research Dissertation Program Announcement PAR-07-231 Total Direct Costs: $35,000 10/22/07 - 12/31/07 Role: PI (15%) “BacLite for the detection of MRSA” 3M Medical Diagnostics Total Direct Costs: $40,000 07/01/08 - 06/30/09 Role: Co-PI (5%) PI: R. Venezia “Detection of MRSA from Blood Cultures” Microphage Total Direct Costs: $21,000 02/01/10 - 02/01/11 Role: PI (5%) “Clinical Validation of the Molecular-based BD GeneOhm VanR assay for the presumptive identification of vancomycin resistant Enterococci in perianal and/or rectal specimens” Becton Dickinson Total Direct Costs: $75,000 04/15/10 - 07/31/11 Role: Site PI (in kind/mentor) PI: M. Schweizer “Linezolid Therapy and Outcomes in Patients with Post-Influenza Staphylococcus aureus Pneumonia, Controlling for Patient, Pathogen, and Treatment Characteristics” Pfizer 06/01/10 - 11/30/13 Role: Co-Investigator (5%) PI: A.D. Harris “Epidemiology of emerging pathogens among hospitalized patients” 2R01AI060859-05 Renewal Direct Costs: $900,000 Indirect Costs: $436,500 Total Direct Costs: $100,000 06/28/10 - 12/01/11 Role: Co-Investigator (5%) PI: K Thom Maryland MDR Acinetobacter Prevalence Survey 3U50CI000485 Maryland Department of Health and Mental Hygiene Direct Costs: $178,000 07/26/10 - 07/25/12 Role: Co-Investigator (5%) PI: J. Furuno Page 12 JKJohnson 08/16/10 - 08/14/13 03/01/11 - 02/28/15 08/01/11 - 07/31/14 10/01/11 - 09/30/12 01/31/12 - 02/01/14 08/01/12 - 07/31/13 08/01/12 - 07/31/14 12/10/12 - 07/31/14 “Using Nursing Home Antibiograms to Improve Antibiotic Prescribing and Delivery” AHRQ HHSA290200600020I Direct Costs: $621,298 Role: Co-Investigator (5%) PI: A.D. Harris “Novel Interventions to Decrease Healthcare Associated Infections” AHRQ (Choice) Direct Costs: $1,064,827 Role: Co-Investigator (5%) PI: M.C. Roghmann “Human Microbiome and Healthcare-associated Infections” National Institutes of Health, National Institute of Allergy and Infectious Diseases R01 Total Direct Costs: $1,134,557 Total Indirect Costs: $567,279 Role: Co-Investigator (10%) PI: M.C. Roghmann “Modifying Isolation Precautions for MRSA in Long Care Setting” Agency for Healthcare Research and Quality Total Direct Costs: $1,012,297 Total Indirect Costs: $338,262 Role: PI (no salary for PI) “Drug Resistant Gram Negative Microorganisms in VA Long Term Care Facilities” Baltimore Research and Education Foundation, Inc. Total Direct Cost: $19,500 Role: PI (10%) “A novel agent to decrease contamination of hospital scrubs” BioMed Protect Inc. Total Direct Costs: $80, 845 Total Indirect Costs: $43, 252 The contract is with the UMB SOM Center for Clinical Trials. Role: Principal Investigator (2%) “Clinical Evaluation of the FilmArray Blood Culture Identification System” Idaho Technologies Direct Costs: $90,451 Indirect Costs: $42,964 Role: Principal Investigator (10%) “Development of a PCR Assay for the detection of MRSA” Maryland Industrial Partnership (MIPS) Direct Costs: $87, 948 Indirect costs: $16,468 Role: Principal Investigator (2%) “Bacterial Identification and Susceptibility Reference Testing of Gramnegative Blood Culture Project” Nanosphere Page 13 JKJohnson 02/01/13 - 02/28/14 09/15/13 - 09/14/14 10/01/13 - 01/30/16 11/08/13 - 10/31/15 01/14/14 - 01/13/15 04/24/14 - 04/23/15 05/06/14 - 05/05/15 Direct Costs: $245,700 Indirect Costs: $105,300 Role: Co-Investigator of project (no salary support) PI: Fraser-Liggett Contract/grant#: HHSN272200900009C “Genome Sequencing Centers for Infectious Diseases” Project Title: Comparative genomics and transcriptomics to identify genetic mechanisms underlying the emergence of carbapenem resistant Acinetobacter baumannii (CRAb) National Institutes of Health/National Institute of Allergy and Infectious Diseases Role: Co-Investigator (10%) PI: R Christenson “Specimen Acquisition for Hepatitis Evaluations” Roche Direct Costs: $138,347.30 Indirect Costs: $35,970.30 Role: Principal Investigator (2%) Sentinel Site Surveillance for AR Organisms CDC-SHEPheRD Program Contract RFTOP 2013-001 Direct Cost: $78,500 Indirect Cost: $20,500 Role: Co-PI (10%) PI: Harris, AD “Risk factors for Pseudomonas on ICU admission and Prevalence of antibiotic-resistant Pseudomonas on admission” Cubist Direct Costs: $110, 847.18 Indirect Costs: $27,711.80 Role: Principal Investigator (2%) Verigene Gram-Negative Blood Culture Test: “Rapid identification of Gram-negative Organisms and resistance in blood stream infections” Nanosphere Direct Costs: $28, 192 Indirect Costs: $8, 457.60 Role: Principal Investigator (2%) “High Risk MDRO Gene Panel Beta Performance Evaluation” OpGen Direct Costs: $59,389 Indirect Costs: $17,817 Role: Principal Investigator (2%) “Clinical Evaluation of the FilmArray Meningitis/Encephalitis Panel” Bio-Fire Diagnostics Direct Costs: $39,000 Indirect Costs: $11,700 Publications (Name change from Miller to Johnson in 2002) Peer-reviewed journal articles Page 14 JKJohnson 1. Miller, J.K., and D.E. Lenz. Development of an Immunoassay for Diagnosis of Exposure to Toxic Organophosphourus Compounds. J. Appl. Toxicol. 2001. 21(S1):S23-S26. PMID: 11920916 2. Johnson, J.K., D.M. Cerasoli, and D.E. Lenz. Role of Immunogen Design in Induction of Soman-specific Monoclonal Antibodies. Immunology Letters. 2005. Immunology Letters 96(1); 121-127. PMID: 15585315 3. Chan-Tack K.M. and J.K. Johnson. Photo Quiz: An Unusual Gram Stain Finding. Clin. Infect. Dis. 2005. 40(11); 1649 and 1677. PMID: 15895484 4. Jabra-Rizk M.A., J.K. Johnson, G.N. Forrest, K. Mankes, T.F. Meiller, R.A. Venezia. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis. 2005. Oct 1;41(7):1064-7 PMID: 16142677 5. Mehta S, J. Johnson, R.A. Venezia, G.N. Forrest. Emergence of linezolid-resistant Enterococci in a neutropenic patient. J Hosp Infect. 2006. 62:125-7. PMID: 16099544 6. Furuno JP, J.C. McGregor, A.D. Harris, J.A. Johnson, J.K. Johnson, P. Langenberg, R.A. Venezia, J. Finkelstein, D.L. Smith, S.M. Strauss, E.N. Perencevich. Identifying High-Risk Groups for Carriage of Antibiotic-Resistant Bacteria. Arch Intern Med. 2006. 166:580-585. PMID: 16534047 7. Johnson J.K., E.N. Perencevich, D.P. Lincalis, R.A. Venezia. Dog Bite Transmission of Antibiotic Resistant Bacteria to a Human. Infect Control Hosp Epidemiol. 2006. 27:762-763. PMID: 16807855 8. Forrest, G.N., S. Mehta, E. Weekes, D.P. Lincalis, J.K. Johnson, R.A. Venezia. Impact of Rapid in-situ Hybridization Testing on Coagulase Negative Staphylococci positive Blood Cultures. J Antimicro. Chemo. 2006. 58:154-158. PMID: 16636084 9. Forrest, G.N., K. Mankes, M.A Jabra-Rizk, E. Weekes, J.K. Johnson, D.P. Lincalis, R.A. Venezia. Impact of PNA FISH of Candida albicans on antifungal therapy, mortality and costs. J. Clin Microbiol. 2006. 44: 3381-3383. PMID: 16954279 10. Harris A.D., M. Kotetishvilli, S. Shurland, J.A. Johnson, J.G. Morris, J.K. Johnson. How Important is Patient-to-Patient Transmission in Extended Spectrum β-Lactamase Escherichia coli Acquisition. Am J Infect Control. 2007. 35: 97-101. PMID: 17327188 11. Wright, M.O., J.P. Furuno, RA Venezia, J.K. Johnson, H.C. Standiford, J.N. Hebden, J. Hill, D.M. Hartley, A.D. Harris, E.N. Perencevich. Methicillin-resistant Staphylococcus aureus among hospitalized prisoners. Infect Control Hosp Epidemiol. 2007. 28:877-879. PMID: 17564994 12. Johnson, J.K., T. Khoie, S. Shurland, K. Kreisel, O.C. Stine, M.C. Roghmann. Skin and Soft Tissue Infections from Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 Clone. Emerg Infect Disease. 2007. 13:1195-1200. PMC: 2828080 13. Harris, A.D., E.N. Perencevich, J.K. Johnson, D.L. Patterson, J.G. Morris, S. Strauss, J. A. Johnson. Patient-to-Patient Transmission is Important in Extended Spectrum beta-LactamaseProducing Klebsiella pneumoniae Acquisition. Clin Infect Dis. 2007. 45:1347-1350. PMID: 17968833 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 14. Johnson, J.K., S.M. Arduino, O.C. Stine, J.A. Johnson, A.D. Harris. Multilocus Sequencing Typing Compared to Pulsed-Field Gel Electrophoresis for Molecular Typing of Pseudomonas aeruginosa. J. Clin Microbiol. 2007. 45:3707-3712. PMC: 2168506 Page 15 JKJohnson 15. Forrest, G.N, E. Weekes, J.K. Johnson. Increasing incidence of Candida parapsilosis candidemia with echinocandin usage. J Infect. 2008. 56:126-129. PMID: 18082269 16. Riedel, D.J, J.K. Johnson, G.N. Forrest. Rhodotorula glutinis fungemia in a liver–kidney transplant patient. Transplant Infectious Disease. 2008. 10:197-200. PMID: 17605726 17. Laurens, M.B., R.M. Becker, J.K. Johnson, J.S. Wolf, K.L. Kotloff. MRSA with progression from otitis media and sphenoid sinusitis to clival osteomyelitis, pachymeningitis and abducens nerve palsy in an immunocompetent 10 year-old patient. International Journal of Pediatric Otorhinolaryngology 2008. 72:945-951. PMID: 18472169 18. Shepard, J.R., R.M. Addison, B.D. Alexander, P. Della-Latta, M. Gherna, G. Hall, G. Haase, J.K. Johnson, W.G. Mer, H. Peltroche-Llacsahuanga, G.W. Procop, H. Stender, R. A. Venezia, D. Wilson, F. Wu, M.J. Fiandaca. Multicenter Evaluation of the C. albicans/C. glabrata PNA FISH method for Simultaneous Dual Color Identification of Candida albicans and Candida glabrata Directly from Blood Culture Bottles. J. Clin Microbiol. 2008. 46: 50-55. PMID: 17977998 19. Schweizer M.L., J.P. Furuno, A.D. Harris, J.C. McGregor, K.A. Thom, J.K. Johnson, M.D. Shardell, E.N. Perencevich. Clinical Utility of Infection Control Documentation of Prior History of Methicillin-resistant Staphylococcus aureus Colonization or Infection. Infect Control Hosp Epidemiol. 2008.29:972-974. PMID: 18793097 20. Forrest, G.N., M.C. Roghmann, L.S. Toombs, J.K. Johnson, E. Weeks, D.P. Lincalis, R.A. Venezia. PNA-FISH for Hospital Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy. Antimicrob. Agents Chemother. 2008. 52:3558-63. PMID: 18663022 21. Shurland, S. J.P. Furuno, R.A. Venezia, J.K. Johnson, M.C. Roghmann. Colonization Sites of USA300 Methicillin-Resistant Staphylococcus aureus in Extended Care Residents. Infect Control Hosp Epidemiol. 2009. 30: 313-318. PMID: 19239380 22. Johnson, J.K., G. Smith, M. S. Warren, R. A. Venezia, O. C. Stine, J. P. Nataro, W. Hsiao, A. D. Harris. The Role of Patient-to-Patient Transmission in the Acquisition of Imipenemresistant Pseudomonas aeruginosa Colonization in the Intensive Care Unit. Journal of Infectious Diseases. 2009. 200: 900-905. PMID: 19673646 Editorial by E. Laetenbach. Antimicrobial Resistance in Gram-Negative Pathogens: Crafting the Tools Necessary to Navigate the Long Ascent out of the Abyss. Journal of Infectious Diseases 2009. 200: 838-40. PMID: 19673645 23. Kreisel, K., M.C. Roghmann, M. Shardell, O.C. Stine, E.Perencevich, A.Lesse, F.Gordin, M. Climo, J.K. Johnson. Assessment of the 48-Hour Rule for Identifying Community-Associated Methicillin-Resistant Staphylococcus aureus Infections Complicated by Bacteremia. Infect Control Hosp Epidemiol. 2010. 31(6); 657-9. PMID: 20412012 24. Morgan D., S. Liang, C. Smith, J.K. Johnson, A.D. Harris, J.P. Furuno, K.A. Thom, G. Snyder, H. Day, E.N. Perencevich. Frequent Multidrug-resistant Acinetobacter baumannii Contamination of Gloves, Gowns and Hands of Healthcare Workers. Infect Control Hosp Epidemiol. 2010. 31(7); 716-21. PMID: 20486855 25. Kreisel, K., J.K. Johnson, O.C. Stine, M. Shardell, EN. Perencevich, A. Lesse, F. Gordin, M. Climo, M.C. Roghmann. Illicit Drug Use and Risk for USA300 Methicillin-Resistant Staphylococcus aureus Infections with Bacteremia. Emerg Infect Disease. 2010. 16(9) (Medscape CME article) PMC: 3294968 26. Rasmussen, A.K.I., R.L. Skov, R.A. Venezia, J.K. Johnson, H. Stender. Evaluation of mupA EVIGENE® assay for Determination of High-Level Mupirocin Resistance in Staphylococcus aureus. J. Clin Microbiol. 2010. 48:4253-5. PMID: 20810775 Page 16 JKJohnson 27. Shurland S.M., O.C. Stine, R.A. Venezia, J.K. Johnson, M. Zhan, J.P. Furuno, R.R. Miller, C. Pelser, M.C. Roghmann. Prolonged Colonization with USA300 MRSA in Extended Care Residents. Infect Control Hosp Epidemiol. 2010. 38;838-41. PMID: 20569116 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 28. Thom K.A, W. Hsiao, A.D. Harris, O.C. Stine, D. Rasko, J.K. Johnson. Patients with Acinetobacter baumannii bloodstream infection are colonized in the gastrointestinal tract with the identical strains. Am J Infect Control, 2010. 38(9);751-3. PMID: 20570393 29. Harris, A.D., J.P. Furuno, M.C. Roghmann, J.K. Johnson, R. A. Venezia, H. C. Standiford, M. L. Schweizer J. N. Hebden, E. N. Perencevich. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicro Agents Chemother. 2010. 54(8);3143-8. PMID: 20479207 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 30. Schweizer M.L., J.P. Furuno, A.D. Harris, J.K. Johnson, MD. Shardell, J.C. McGregor, K.A. Thom, G. Sakoulas, E.N. Perencevich. Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality. PLoS ONE. 2010. 5(7);e11432. PMID: 20625395 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 31. Morgan, D.J., H.R. Day, J.P. Furuno, A. Young, J.K. Johnson, D.D. Bradham, E.N. Perencevich. Improving Efficiency in Active Surveillance for Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococcus at Hospital Admission. Infect Control and Hosp Epidemiol. 2010. 31(12); 1230-1235. PMID: 21028966 32. Arnold R.S., K.A. Thom, S. Sharma, M. Phillips, J.K. Johnson, D.J. Morgan. Emergence of Klebsiella pneumoniae Carbapenemase (KPC)-Producing Bacteria. South Med J. 2011. 10491:40-5. PMID: 21386985 33. Schweizer M.L., J.P. Furuno, G. Sakoulas, J.K. Johnson, A.D. Harris, M.D. Shardell, J.C. McGregor, K.A. Thom, E.N. Perencevich. Increased Mortality with Accessory Gene Regulator (agr)-Dysfunction in Staphylococcus aureus among Bacteremic Patients. Antimicrob Agents Chemother. 2011. 55(3);1082-7. PMID: 21173172 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 34. Furuno J.P., S.M. Shurland, M. Zhan, J.K. Johnson, R.A. Venezia, A.D. Harris, M.C. Roghmann. Comparison of the methicillin-resistant Staphylococcus aureus acquisition among rehabilitation and nursing home residents. Infect Control and Hosp Epidemiol. 2011. 32(3); 2449. PMID: 21460509 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 35. Ajao A.O., A.D. Harris, M.C. Roghmann, J.K. Johnson, M. Zhan, J.C. McGregor, J.P. Furuno. A Systematic Review of Measurement and Adjustment for Colonization Pressure in Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci and Clostridium difficile Acquisition Studies. Infect Control and Hosp Epidemiol. 2011. 32(5);481-9. PMID: 21515979 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. Page 17 JKJohnson 36. Sahl J.W., J.K. Johnson, A.D. Harris, A.M. Phillippy, W.W. Hsiao, K.A. Thom, D.A. Rasko. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics. 2011. 12:291. PMID: 21639920 37. Harris A.D., J.K. Johnson, K.A. Thom, D.J. Morgan, J.C. McGregor, A.O. Ajao, A.C. Moore, A.C. Comer, J.P. Furuno. Risk factors for Development of Intestinal Colonization with Imipenem-resistant Pseudomonas aeruginosa in the Intensive Care Unit Setting. Infect Control and Hosp Epidemiol. 2011. 32(7): 719-22. PMID: 21666406 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 38. Schweizer ML, Furuno JP, Harris AD, Johnson J.K., Shardell MD, McGregor JC, Thom KA, Sakoulas G, Perencevich EN. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infectious Diseases. 2011. 11:279. PMID: 22011388 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 39. Roghmann M.C., J.K. Johnson, O.C. Stine, A. Lydecker, K. Ryan, B.D. Mitchell, A.R. Shuldiner. Persistent Staphylococcus aureus colonization is not a strongly heritable trait in Amish families. PLoS One. 2011. 6(2):e17368. PMID: 21386985 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 40. Kreisel, K.M., O.C. Stine, J.K. Johnson, E.N. Perencevich, M.D. Shardell, A.J. Lesse, F.M. Gordin, M.W. Climo, M.C. Roghmann. USA300 Methicillin-Resistant Staphylococcus aureus Bacteremia and the Risk of Severe Sepsis: Is USA300 MRSA Associated with More Severe Infections? Diagn Microbiol Infect Dis. 2011. 70(3):285-90. PMID: 21558047 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 41. Ajao A.O., G. Robinson, M. Lee, T. Ranke, R.A. Venezia, J.P. Furuno, A.D. Harris, J.K. Johnson. Comparison of Culture Media for Detection of Acinetobacter baumannii in Surveillance Cultures of Critically-ill Patients. Eur J Clin Microbiol Infect Dis. 2011. 32(5);4819. PMID: 21487763 42. Thom K.A., J.K. Johnson, M. Lee, A.D. Harris. Environmental contamination because of multidrug-resistant Acinetobacter baumannii surrounding colonized or infected patients. Am J Infect Control. 2011. 39(9):711-5. PMID: 22041290 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 43. Furuno, J.P., J.K. Johnson, M.L. Schwizer, A. Uche, O.C. Stine, S.M. Shurland, G.N. Forrest. Community-associated Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis among HIV Patients: a cohort study. BMC Infectious Diseases. 2011. Oct 31. 11;298. PMID: 22040268 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 44. Morgan DJ, Rogawski E, Thom KA, Johnson J.K., Perencevich EN, Shardell M, Leekha S, Harris AD. Transfer of Multidrug-Resistant Bacteria to Healthcare Workers’ Gloves and Gowns After Patient Contact Increases with Environmental Contamination. Crit Care Med. 2012. 40(4); 1045-51. PMID: 22202707 Page 18 JKJohnson Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 45. Hazen TH, G Robinson, AD Harris, DA Rasko, J.K. Johnson. Genome sequence of Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC β-lactamase. J. Bacteriol. 2012. 194; 3028-29. PMID: 22582383 46. Thom KA, Howard T, Sembajwe S, Harris AD, Strassle P, Caffo BS, Carroll K, Johnson J.K. Comparison of Swab versus Sponge Methodology for the Identification of Acinetobacter baumannii from the Hospital Environment. J Clin Microbiol. 2012. 50 (6):2140. PMID: 22461673 47. Robinson, G., AD Harris, DJ Morgan, L Pineles, B Belton, and J.K. Johnson And the Benefits of Universal Gloving and Gowning (BUGG) Study group. Survival of MethicillinResistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) for an extended period of transport. J Clin Microbiol, 2012. 50(7); 2466-68. PMID: 22535993 48. Ranke, T., AD Harris, P Strassle, and J.K. Johnson. The Recovery of Gram Negative Bacilli in Stored Endotracheal Aspirate Samples. J Clin Microbiol, 2012. 60 (8); 2791-2. PMID: 22649011 49. Thom KA, Maragakis LL, Richards K, Johnson J.K., Roup B, Lawson P, Harris AD, Fuss EP, Pass MA, Blythe D, Perencevich EN, Wilson L. Assessing the Burden of Acinetobacter baumannii in Maryland: A Statewide Cross-sectional Period Prevalence Survey. Infect Control Hosp Epidemiol, 2012. 33(9); 883-888. PMID: 22869261 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 50. A.S. Hess, M. Shardell, J.K. Johnson, K.A. Thom, P. Strassle, G. Netzer, A.D. Harris. Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis. 2012. 31 (9):2111-6. PMID: 22476385 51. Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson J.K., Nguyen C, Chen WH, Roghmann MC. Lower Antibody Levels to Staphylococcus aureus Exotoxins are associated with Sepsis in Hospitalized Adults with Invasive Staphylococcus aureus Infections. Journal of Infectious Diseases. 2012. 206 (6):915-23. PMID: 22807524 52. Strassle P, Thom KA, Johnson J.K., Leekha S, Lissauer M, Zhu J and Harris AD. The effect of terminal contamination rates of multidrug-resistant Acinetobacter baumanii. Amer J Infection Control. 2012. 40(10); 1005-7. PMID: 23199726 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 53. Ajao AO, Harris AD, Johnson J.K., Roghmann M, Perencevich EN, Schweizer ML, Zhan M, Chen WH, Furuno JP. Association between Methicillin-resistant Staphylococcus aureus Colonization and Infection May Not Differ by Age Group. Infect Control Hosp Epidemiol. 2013. 34; 93-95. PMID: 23221199 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 54. Ajao AO, Johnson J.K., Harris AD, Zhan M, McGregor JC, Thom KA, Furuno JP. Risk of Acquiring Extended-Spectrum Beta-lactamase-Producing Klebsiella Species and Escherichia coli from Prior Room Occupants in the Intensive Care Unit. Infect Control Hosp Epidemiol. 2013. 34: 453-458. PMID: 23571360 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. Page 19 JKJohnson 55. A.S. Hess, M. Shardell, J.K. Johnson, K.A. Thom, MC Roghmann, G. Netzer, DJ Morgan, A.D. Harris. A Randomized Controlled Trial of Enhanced Cleaning to Reduce Contamination of Healthcare Worker Gowns and Gloves with Multidrug-Resistant Bacteria. Infect Control Hosp Epidemiol. 2013. 34: 453-458. PMID: 23571365 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 56. Rock C, Harris AD, Reich NG, Johnson J.K., Thom KA. Is hand hygiene before putting on non-sterile gloves in the ICU a waste of healthcare worker time? A randomized controlled trial. Am J Infect Control. 2013. 41(11): 994-6. PMID: 23891455 Directed laboratory work and personnel and reviewed, interpreted, analyzed, and published data. 57. Harris AD, Pineles L, Belton B, Johnson J.K., Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ and the Benefits of Universal Glove and Gown (BUGG) Investigators. Universal Glove and Gown use and Acquisition of AntibioticResistant Bacteria in the ICU: A Randomized Trial. JAMA. 2013. 310 (15)1571-80. PMID: 24097234 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 58. D.A.T. Shirley, E.L. Heil, J.K. Johnson. Ceftaroline Fosamil: A Brief Clinical Review. Infectious Diseases and Therapy. 2013. 2(2):95-100. PMID: 25134474 59. Roghmann MC, Longinaker N, Croft L, Johnson J.K., Lydecker AD, Stine OC. Molecular Epidemiology of Staphylococcus aureus colonization among the Older Order of Amish of Lancaster, PA. Epidemiology and Infection 2014. 142(8):1722-6. PMID: 24230465 60. Johnson J.K., Wilson LE, Zhao L, Richars K, Thom KA, Harris AD. Point Prevalence of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae (KPCS) in Maryland. Infect Control Hosp Epidemiol. 2014. 35(4):443-445. PMID: 24602955 61. Rock, C, Thom KA, Masnick M, Johnson J.K., Harris AD, Morgan DJ. Frequency of Klebsiella pneumoniae Carbapenemase (KPC)-Producing and Non-KPC-Producing Klebsiella Species Contamination of Healthcare Workers and the Environment. Infect Control Hosp Epidemiol. 2014. 35(4):426-429. PMID: 24602950 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 62. Hazen TH, Zhao L, Sahl JW, Robinson GP, Harris AD, Rasko DA, Johnson J.K. Characterization of Klebsiella sp. 10982, a colonizer of humans that contains novel antibiotic resistance alleles and exhibits genetic similarities to plant and clinical Klebsiella isolates. Antimicrob Agents Chemother. 2014. 58 (4):1879-88. PMID: 24395222 63. Hess AS, Kleinberg M, Sorkin JD, Netzer G, Johnson J.K., Shardell M, Thom KA, Harris AD, Roghmann MC. Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients. Diagn Microbiol Infect Dis. 2014. May;79;73-6. PMID: 24582582 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 64. Hazen TH, Zhao L, Boutin MA, Stancil A, Robinson GP, Harris AD, Rasko DA, Johnson J.K. Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella species isolated from ICU patients: the utility of whole genome sequencing in healthcare settings. Antimicrob Agents Chemother. 2014. 58(8):4814-25. PMID: 24914121 Page 20 JKJohnson 65. Papp-Wallace, K., M. Winkler, J. Gatta, M. Taracila, S. Chilakala, Y. Xu, J. Johnson, R. Bonomo. Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of ceftazidime against CMY-2 producing Escherichia coli. Antimicrob Agents Chemother. 2014. 58(8): 4290-7. PMID: 24820081 66. Thom, KA, HC Standiford, J.K. Johnson, N Hanna, JP Furuno. Effectiveness of an Antimicrobial Polymer to Decrease Contamination of Environmental Surfaces in the Clinical Setting. Infect Control Hosp Epidemiol. 2014. 35(8): 1060-1062. PMID: 25026625 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 67. Furuno JP, Comer AC, Johnson J.K., Rosenberg JH, Moore SL, MacKenzie TD, Hall KK, Hirshon JM. Using Antibiograms to Improve Antibiotic Prescribing in Skilled Nursing Facilities. Infect Control Hosp Epidemiol. 35:S3:S56-S61. PMID: 25222899 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 68. Boutin, MA, KA Thom, M Zhan, J.K. Johnson. A Randomized-crossover trial to decrease bacterial contamination on hospital scrubs. Infect Control Hosp Epidemiol. 2014. 35(11):14111413. PMID: 25333437 69. J Bork, W Wilding, CW Claassen, J.K. Johnson, M. Kleinberg. Photo Quiz: Fungal Sinusitis in a 75-Year-Old Neutropenic Cancer Patient. Clinical Infectious Diseases. Clin Infect Dis. 2015. Jan 15;60(2):274. Answer 321-2. PMID: 25538223 70. J Bork, S Leekha, E Heil, L Zhao, R Badoamas, J.K. Johnson. Rapid Testing Using Verigene Gram-Negative Blood Culture Nucleic Acid Test with Combination with Antimicrobial Stewardship Intervention Against Gram-Negative Bacteremia. Antimicrob Agents Chemother. 2015. Mar;59(3):1588-95. PMID: 25547353 71. Rock C, Harris AD, Johnson J.K., Bischoff WE. Thom KA. Infrequent Air Contamination with Acinetobacter baumannii of Air Surrounding Known Colonized or Infected Patients. Infect Control Hosp Epidemiol. 2015. 36(7):830-2. PMID: 25825865 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 72. Roghmann MC, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L Mody. Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA) to Healthcare Worker Gowns and Gloves During Care of Nursing Home Residents. Infect Control Hosp Epidemiol. 2015. 36(9):1050-7. PMID: 26008727 Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed, and published data. 73. Hines MC, T AL-Salamah, EL Heil, H Mallemat, M Witting, J.K. Johnson, M Winters, BD Hayes. Resistance patterns of Escherichia coli in women with uncomplicated urinary tract infection do not correlate with Emergency Department antibiogram. Journal of Emerg Med. 2015. 49(6):998-1003. PMID: 26281821 74. McDanel JS, Perencevich EN, Diekema DJ, Winokur PL, Johnson J.K., Herwaldt LA, Smith TC, Chrischilles EA, Dawson JD, Schweizer ML. Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study. Antimicrob Resist Infect Control. 2015. 4:51. PMID: 26668737 Page 21 JKJohnson 75. Morgan, DJ, S Leekha, L Croft, CA Burnham J.K. Johnson, L Pineles, AD Harris, ER Dubberke. The Importance of Colonization with Clostridium difficile on Infection and Transmission. Curr. Infect Dis Rep. 2015. 17(9): 499. PMID: 26239132 76. Epstein L, J Edwards, AL Halpin, MA Preas, D Blythe, AD Harris, D Hunt, J.K. Johnson, M Filippell, CV Gould, S Leekha. Evaluation of a Novel Intervention to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital, Maryland 2011-2014 Infect Control Hosp Epidemiol. 2016. 37(5):544-8. PMID: 26832608 77. Sarg M, G Waldrop, M Beier, EL Heil, KA Thom, MA Preas, J.K. Johnson, AD Harris, S Leekha. Impact of Changes in Urine Culture Ordering Practice on Antimicrobial Utilization in Intensive Care Units at an Academic Medical Center Infect Control Hosp Epidemiol. 2016. 37:448-454. PMID: 26778179 78. Harris AD, SS Jackson, G Robinson, L Pineles, S Leekha, KA Thom, M Doll, MM Pettigrew and J.K. Johnson. Pseudomonas aeruginosa colonization n the ICU: Prevalence, risk factors and clinical outcomes. Infect Control Hosp Epidemiol. 2016. 37(5):544-8. PMID: 26832307 79. OC Stine, S Burrowes, S David, J.K. Johnson, MC Roghmann. Transmission Clusters of Methicillin-Resistant Staphylococcus aureus in Long-Term Care Facilities Based on WholeGenome Sequencing. Infect Control Hosp Epidemiol. 2016. 37(6):685-91. PMID: 26941060 80. RG D’Angelo, J.K. Johnson, JT Bork, EL Heil. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria. Expert Opin Pharmacother. 2016. 17 (7):953-67. PMID: 26891857 81. McDanel JS, Perencevich EN, Storm J, Diekema DJ, Herwaldt L, Johnson J.K., Winokur PL, Schweizer ML. Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA. Emerg Infect Dis. 2016. 22(7):1253-6. PMID: 27315549 82. Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson J.K., Robinson G, Carroll KC, Greer A, Morgan M, Chan R, Loeffelholz M, Valencia-Shelton F, Jenkins S, Schuetz AN, Daly JA, Barney T, Hemmert A, Kanack KJ. Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin Microbiol. 2016. 54(3):687-98. PMID: 26739158 83. Wiener ES, E Heil, LM Hynicka, J.K. Johnson. Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacilli? Journal of Pharmacy Technology. 2016. 32:16-21. 84. Heil E and J.K. Johnson. Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs. 2016. J Clin Microbiol. 54(4):840-4. PMID: 26791363 85. Pettigrew MM, J.K. Johnson, AD Harris. The human microbiota: Novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol. 2016. 26(5):342-7. PMID: 26994507 86. Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson J.K., Soliven NL, Carroll K, Miller JA, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac K. Multicenter Evaluation of the BioFire FilmArray Meningitis Encephalitis Panel for the Detection of Bacteria, Viruses and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol. 2016. [Epub ahead of print]. PMID: 27335149 Page 22 JKJohnson 87. Wallace L, SC Daugherty, S Nagaraj, JK Johnson, AD Harris, DA Rasko. The use of comparative genomics to characterize the diversity of Acinetobacter baumannii surveillance isolates in a health care institution. Antimicrob Agents Chemother. 2016. (Epub ahead of prient). PMID: 27458211 88. JK Johnson, GL Robinson, L Zhao, AD Harris, OC Stine, KA Thom. Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis. 2016. (accepted). 89. E Kong, JK Johnson, MA Jabra-Rizk. Community Associated methicillin-resistant Stapylococcus aureus: An Enemy Amidst Us. PLOS Pathogens. 2016. (accepted) 90. G Kumarachandran, JK Johnson, E Graffunder, DA Shirley, EL Heil. Predictors of adverse outcomes in children with Staphylococcus aureus bacteremia. Journal of Pediatric Pharmacology and Therapeutic. 2016. (accepted) Non-peer reviewed journal articles 1. Johnson, J.K. and D. Cashara. 2013. Current Rapid Screening Methods for Gastrointestinal Colonization of Vancomycin Resistant Enterococci (VRE). Clinical Microbiology Newsletter. 35(6);46-51. Available at: http://www.sciencedirect.com/science/article/pii/S019643991300010X 2. Hirshon JM, Comer AC, Rosenberg JH, Johnson J.K., Moore SL, MacKenzie TD, Hall KK, Furuno JP. Methodological Challenges Associated with Developing and Implementing Antibiograms in Nursing Homes. Advances in the Prevention and Control of HAIs. June 2014. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.ahrq.gov/professionals/quality-patient-safety/patient-safetyresources/resources/advances-in-hai/hai-article9.html Abstracts 1. Miller, J.K., and D.E. Lenz. Development of an Immunoassay for Diagnosis of Exposure to Toxic Organophosphourous Compounds. 1998. (Proceeding of the 1998 Medical Defense Bioscience Review, Hunt Valley, MD) 2. Miller, J.K., D.M. Cerasoli, A.A. Brimfield and D.E. Lenz. A Model System For Examining the Role of Epitope Structure in Determining Monoclonal Antibody Specificity. 1999. Fed Proc 13(4), A333. (Abstract number 258.9) 3. Cerasoli, D.M., J.K. Miller, J.J. Schlager, J.H. Clark, R. Morlarty, A.A. Brimfield, and D.E. Lenz. Binding Properties of Antibodies Raised Against Structurally Different Transition State Analog Immunogens. 1999. Fed Proc 13(4), A333. (Abstract number 258.10). 4. Miller, J.K., D.M. Cerasoli, and D.E. Lenz. Characterization of Antibodies Toward a Biologically Active Hapten. 2000. FASEB Journal 14 (6), A956. (Abstract number 44.6) 5. Miller, J.K., D.M. Cerasoli, A.C. Buenafe, MB Rittenberg, and D.E. Lenz. Sequence Differences in Light Chain Genes Affect the Binding Specificity of Anti-hapten Antibodies. 2001. FASEB J. 15 (4): A339 (Abstract number 274.4) 6. Wright M.O., Venezia R.A., Johnson J.K., Furuno J.P., Standiford H.C., Hebden J.N., Hill J.H., and Perencevich E.N. Methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients transferred from correctional facilities (CF): the Maryland Experience. 2004. Interscience Conference on Antimicrobial Agents and Chemotherapy 44:378. (Abstract K1856) Page 23 JKJohnson 7. Furuno J.P., McGregor J.C., Harris A.D., Johnson J.A., Johnson J.K., Langenberg P., Venezia R.A., Finkelstein J., Smith D.L., Perencevich E.N. Identifying Patients at High Risk for Colonization by Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci upon Hospital Admission: Use of a Clinical Prediction Rule. 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. April 2005. Los Angeles, CA. 8. Rizk, M.A., J.K. Johnson, M. Shirtliff, K.M. Oliveira, K. Haverkos, T.F. Meiller. PNA FISH Analysis of Microbial Biofilms. American Society of Microbiology 105th General Meeting. June 2005. Atlanta, GA. (Abstract J-018) 9. Rizk, M.A., M.E. Shirtliff, J.K. Johnson, S.J. Arley, T.F. Meiller. Effect of Farnesol on Mixed Species Biofilm. American Society of Microbiology 105th General Meeting. June 2005. Atlanta, GA. (Abstract J-018) 10. Rizk, M.A., J.K. Johnson, K. Mankes, G. Forrest, T.F. Meiller, R.A. Venezia. Candida dubliniensis Fungemia. American Society of Microbiology 105th General Meeting. June 2005. Atlanta, GA. (Abstract F-019) 11. Mankes, K., G.N. Forrest, M.A. Jabra-Rizk, J.K. Johnson, R.A. Venezia. Outcomes of Peptide Nucleic Acid Fluorescence in situ Hybridization Probes for Rapid Identification of Candida albicans. 43rd IDSA Meeting. October 2005. San Francisco. (Abstract 276) 12. Thom, K., K. Mankes, G. Forrest, M. Rizk, M. Caplan, J. Johnson, R.A. Venezia. A Treatment Algorithm Using Rapid Diagnosis of Candidemia with Fluconazole Susceptibility Testing. Interscience Conference on Antimicrobials and Chemotherapy 45th Meeting. December 2005. Washington, D.C. (Abstract O-179) 13. Johnson, J.K., A.A. Roberts, G.N. Forrest, D.P. Lincalis, R.A. Venezia. Rapid Identification of Enterococcus species in Positive Blood Cultures with Therapeutic Implications. American Society of Microbiology 106th General Meeting. May 2006. Orlando, Florida. (Abstract C-147) 14. Roghmann, M.C., T. Khoie, S. Shurland, K. Kreisel, J.K. Johnson, A. Feller, E. Tai, O.C. Stine, J.A. Johnson, D. Jerrard and J. Flanagan. Increase in Skin and Soft Tissue Infections associated with an Increase in Community-associated Methicillin Resistant S. aureus Infections. Veterans Administration Research Day. May 2006. Baltimore, Maryland. 15. Shurland, S., J.K. Johnson, K. Kreisel, O. C. Stine, R. A. Venezia, M. C. Roghmann. Pulsed Field Type USA300 MRSA is Endemic in a Long-Term Care Unit. At the 46th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA September 29, 2006. (Slide Presentation). 16. Johnson, J.K., K. Stellrecht, M. Roghmann, R.A. Venezia. Comparison of Real-time PCR to Culture for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Long Term Care Unit. 46th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2006. San Francisco, CA. (Abstract D-0840) 17. Harris, A.D., M. Kotetishivili, S. Shurland, J.A. Johnson , J.G. Morris Jr., L. Nemoy, J.K. Johnson. Importance of Patient-to-Patient Transmission in Extended Spectrum β-Lactamase (ESBL) Escherichia coli Acquisition. 46th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2006. San Francisco, CA. (Abstract) 18. Yeung, S., E. Weekes, G. Forrest, J.K. Johnson, R.A. Venezia. Clinical Efficacy of Using Vancomycin MICs for Treating Methicillin Resistant Staphylococcus aureus Bacteremia. 44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada. Page 24 JKJohnson 19. Forrest, G., E. Weekes, M.A. Rizk, D. Lincalis, J.K. Johnson, R.A. Venezia. Effectiveness of a Treatment Algorithm for Candidemia Using Rapid Diagnosis. 44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada. 20. Lane, S., R.A. Venezia, J.K. Johnson, G. Forrest. Increasing Resistance to Vancomycin and Daptomycin in MRSA Isolates. 44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada. 21. Weekes, E., G. Forrest, D. Lincalis, J.K. Johnson, R.A. Venezia. Impact of Peptide Nucleic Acid (PNA) Fluorescence in situ Hybridization (FISH) for Enterococcal blood stream infections. 44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada. 22. Wu, F., P. Della-Latta, R. Addison, B. Alexander, G. Procop, D. Wilson, W. Merz, M. Gherna, J.K. Johnson, A. Roberts, J.R. Shepard, M. J. Fiandaca. Dual Color PNA FISH Assay for Simultaneous Identification of Candida albicans and Candida glabrata Directly from Positive Blood Culture Bottles. 44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada. 23. Roghmann M, K. Uduhiri, M. Davis, S. Shurland, M. Zhan, R.A. Venezia, J.K. Johnson. Acquisition of MRSA Colonization in Extended Care Facilities. Society for Healthcare Epidemiology of American (SHEA) National Meeting. April 2007. Baltimore, Maryland. 24. Johnson T, J.K. Johnson, R.A. Venezia, S. Shurland, M. Roghmann. Culture Rules for the Discontinuation of Methicillin-Resistant Staphylococcus aureus (MRSA) Contact Precautions in Extended Care Facilities. Society for Healthcare Epidemiology of American (SHEA) National Meeting. April 2007. Baltimore, Maryland. 25. Harris, A.D., E.N. Perencevich, J.K. Johnson, D.L. Paterson, J.G. Morris, S. Strauss, J.A. Johnson. Patient-to-Patient Transmission is Important in Extended Spectrum beta-LactamaseProducing Klebsiella pneumoniae Acquisition. Society for Healthcare Epidemiology of American (SHEA) National Meeting. April 2007. Baltimore, Maryland. 26. Poulter, M.D., S.I. Getchell-White, G.L. Smith, D.C. Dirks, J.L. Carroll, J.C. Tartaglino, J.K. Johnson. Evaluation of BioRad MRSA SelectTM Chromogenic Agar for Detection of Methicillin Resistant Staphylococcus aureus in Surveillance Samples. American Society of Microbiology 107th General Meeting. May 2007. Toronto, Ontario, Canada. 27. Shurland, S., J.K. Johnson, R. A. Venezia, O. C. Stine, M. Roghmann. Screening for USA300 MRSA: Are the Anterior Nares Adequate? Interscience Conference on Antimicrobials and Chemotherapy 47th Meeting. September 2007. Chicago, Illinois. (Abstract K-448) 28. Standiford, H., J. Hebden, M. Algire, R.A. Venezia, J.K. Johnson. Early Impact of an Extensive Methicillin Resistant Staphylococcus aureus (MRSA) Eradiation Program at an Academic Medical Center on Hospital Acquired MRSA Bacteremia. Interscience Conference on Antimicrobials and Chemotherapy 47th Meeting. September 2007. Chicago, Illinois. (Abstract K459) 29. Veneiza, R.A., M.D. Poulter, G.L. Smith, J.K. Johnson. The Detection of Methicillin Resistant Staphylococcus aureus (MRSA) in Surveillance Samples by a Chromogenic Agar and PCR. Interscience Conference on Antimicrobials and Chemotherapy 47th Meeting. September 2007. Chicago, Illinois. (Abstract D-875) 30. Kreisel, K., Johnson, J.K., Shardell, M., Perencevich, E., Stine, O.C., Roghmann, M. Are people with USA300 MRSA BSI more likely to die? SHEA, Orlando, FL, April 2008. Page 25 JKJohnson 31. A.C. Moore, J.P. Furuno, E.N. Perencevich, T.J. Babineau, M.C. Roghmann, J.K. Johnson, R.A. Venezia, HC. Standiford, J.N. Hebdon, A.D. Harris. Early Lessons on Targeted Whole Hospital Active Surveillance. SHEA, Orlando, FL, April 2008. 32. Venezia, R.A., G. Smith, M.S. Warren, J.K. Johnson. Detection of high level murpirocin in Staphylococcus aureus with molecular probe assay for mupA. American Society of Microbiology 108th General Meeting. May 2008. Boston, MA. (Abstract C-001) 33. Johnson, J.K., R.A Venezia, O.C. Stine, M.S. Warren, A.D. Harris. Are isolates from patients who acquire colonization with imipenem-resistant Pseudomonas aeruginosa and had a previous susceptible strain clonal? At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation). 34. Johnson, J.K., G. Smith, R.A Veneiza, S.M. Strauss, A.C. Moore, A.D. Harris. Patient-toPatient Transmission of Imipenem-Resistant Pseudomonas aeruginosa in the Intensive Care Unit. At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation) 35. Schweizer ML, Sakoulas G, Furuno JP, Johnson J.K., Harris AD, Thom KA, Morgan DJ, Perencevich EP. Increased Mortality with Loss of Function of the accessory gene regulator (agr) in Staphylococcus aureus Bacteremia. At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation). 36. Roghmann M, Shurland SM, Furuno JP, Perencevich EN, Harris AD, Venezia RA, Stine OC, Johnson J.K.. Higher levels of nasal colonization with Methicillin-resistant S. aureus (MRSA) is associated with MRSA Transmission to the Environment in Extended Care Residents. At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation). 37. Thom KA, Standiford HC, Johnson J.K., Strauss SM, Hanna N, Goatee C, Furuno JP. Impact of Antimicrobial Treatment of Environmental Surfaces on Contamination by Important Nosocomial Bacteria. At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation). 38. Forrest, G.M., M.E. Kent, J.K. Johnson, R.A. Venezia. Evaluation of the Candida albicans/C. glabrata (CAG) Peptide Nucleic Acid Fluorescence in Situ Hybridization (PNA FISH) Test on Patient Management. At the joint 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation). 39. Kreisel, K., A. Lesse, F. Gordin, M. Climo, J.K. Johnson, M. Shardell, E. Perencevich, O.C. Stine, M. Roghmann. Is USA300 MRSA BSI Associated with Increased Mortality? 19th Annual Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego, CA, March 20, 2009. 40. Smith C.L, S.Y. Liang, D.J. Morgan, J.K. Johnson, J. P. Furuno, K.A. Thom, G.N. Snyder, A.D. Harris, E.N. PerencevichN. Contamination of healthcare workers’ gowns and gloves with multidrug-resistant Acinetobacter baumannii occurs frequently after patient contact. (Oral Presentation, # 276). 19th Annual Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego, CA, March 20, 2009. Page 26 JKJohnson 41. Johnson, J.K., W. Hsiao, K. Thom, O. C. Stine, A.D. Harris. Patients with Acinetobacter baumannii Bacteremia are Colonized with Identical Strains.19th Annual Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego, CA, March 20, 2009. 42. Schweizer M.L., J.P. Furuno, J.K. Johnson, A.D.Harris, G. Sakoulas, D.J. Morgan, E.N. Perencevich. Increased Vancomycin, Daptomycin and Linezolid Minimum Inhibitory Concentrations (MIC) are Not Associated with Higher Mortality Among Patients with Staphylococcus aureus Bacteremia. Poster Presentation (Presentation # 227). 19th Annual Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego, CA, March 20, 2009. 43. Lincalis, D., R.A. Venezia, J.K. Johnson. PNA FISH S. aureus Procedure Modification Decreases Turn Around Time. American Society of Microbiology 109th General Meeting. May 2009. Philadelphia, PA. (Accepted) 44. Hsiao, W.L., J.K. Johnson, K. Thom, R. Riley, O. C. Stine, A. D. Harris. Patients with Acinetobacter baumannii Bacteremia are Colonized with Identical Strains. American Society of Microbiology 109th General Meeting. May 2009. Philadelphia, PA. (Accepted) 45. Kingery, J.D., P.D. Stamper, L.R. Peterson, E.A. Usacheva, J.K. Johnson, R.A. Venezia, M. Grayson, D. Manandhar, M. Mehta, P. Patel, S. Paule, G. Smith, M. Warren, K.C. Carroll. A Novel Phage Technology for the Detection of S. aureus and differentiation of MSSA and MRSA in Positive Blood Culture Bottles. American Society of Microbiology 109th General Meeting. May 2009. Philadelphia, PA. 46. Johnson, J.K., G. Smith, C.R. Bethel, R.A. Venezia, R.A. Bonono, J.P. Nataro, O.C. Stine, A. D. Harris. Defining Transmission Dynamics among Escherichia coli and Klebsiella spp Possessing Amp C β-lactamases. 49th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2009. San Francisco, CA. 47. Forrest, G., J.K. Johnson, R.A. Venezia. Sustained Effect of Peptide Nucleic Acid Fluorescent in-situ Hybridization (PNA-FISH) on Antimicrobial Utilization and Costs. 49th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2009. San Francisco, CA. 48. Schweizer M., J.P. Furuno, A.D. Harris, J.K. Johnson, M. Shardell, J. McGregor, K.A. Thom, E.N. Perencevich. Nafcillin or 1st Generation Cephalosporins (Naf/ceph1) are Superior Antibiotics for the Treatment of Methicillin-susceptible S. aureus (MSSA) Bacteremia. 49th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2009. San Francisco, CA. (Oral Presentation) 49. Thom K.A., J.K. Johnson, M.S. Lee, A. Lee, A.D. Harris. Multidrug-resistant Acinetobacter baumannii is frequently found on Environmental Surfaces surrounding Colonized or Infected Patients. Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, GA, March 2010. (Oral Presentation) 50. Rogawski E., A.D. Harris, J.K. Johnson, K.A. Thom, E.N. Perencevich, D.J. Morgan. Transfer of Multidrug-resistant Organisms to Healthcare Worker’s Gloves and Gowns after Patient Contact Increases with Environmental Contamination. Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, GA, March 2010. (Oral Presentation) 51. Schweizer M.L., K. Alexander, J.P. Furuno, J.K. Johnson, E.N. Perencevich. Hospital-associated Infection is Associated with Longer Post-infection Length of Stay (LOS) among Pediatric Patients with S. aureus Bacteremia. Poster Presentation. Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, GA, March 2010. Page 27 JKJohnson 52. Johnson, J.K., M. Lee, G. Robinson, T. Ranke, R.A. Venezia, J.P. Nataro. Prevalence of Respiratory Viruses during Influenza Season. 26th Pan American Society of Clinical Virology. April 2010. Daytona Beach, FL. 53. Johnson, J.K., G. Robinson, M. Lee, T. Ranke, R. A. Venezia. Detection of Acinetobacter baumannii in Surveillance Cultures. American Society of Microbiology 110th General Meeting. May 2010. San Diego, CA. 54. Hebden, J, E. Maambo, A.D. Harris, J.K. Johnson. Evaluation of the Two Different Microbiologic Criteria Applied to Common Skin Contaminants in the National Healthcare Safety Network Laboratory-Confirmed Blood stream Infection Definition. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston, MA. 55. Ajao, A.O., T. Ranke, G Robinson, M. Lee, J.P. Furuno, A.D. Harris, K.A. Thom, J.K. Johnson. Detection of Multi-drug resistant Acinetobacter baumannii (MDR-AB) in Peri-rectal Surveillance Cultures for Critically Ill Patients for Infection Control. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston, MA. 56. Standiford, H., J. Hebden, R.A. Venezia, M. Tripoli, M. Emerick, E. Perencevich, A.D. Harris, J.K. Johnson. An Extensive Methicillin-Resistant Staphylococcus aureus (MRSA) Eradication Program at an Academic Medical Center Cost and Effect on Hospital-Acquired MRSA Bacteremia. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston, MA. 57. Roghmann, M.C., J.K. Johnson, O. C. Stine, A. Lydecker, K. Ryan, A. R. Shuldiner, B. D. Mitchell. Lack of Familial Aggregation of Persistent Staphylococcus aureus Colonization in Old Order Amish. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston, MA. 58. Roghmann, M.C., A.O. Ajao, A. Lydecker, R.P. Adhikari, H. Karaizi, W.H. Chen, J.K. Johnson, M.J. Aman. Lower Antibody Levels to Staphylococcus aureus Exotoxins associated with Sepsis in Hospitalized Patients with Invasive S. aureus Infections. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston, MA. (Oral presentation) 59. Ajao A.O., J.K. Johnson, A.D. Harris, M. Zhan, J.C. McGregor, K.A. Thom, J.P. Furuno. Risk of acquiring Extended-spectrum-β-lactamase (ESBL) producing Klebsiella pneumoniae and Escherichia coli from prior room occupants in intensive care unit. Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, Dallas, Texas, April 2011. 60. Ajao A.O., J.P. Furuno, A.D. Harris, M. Lee, G. Robinson, J.K. Johnson. Prevalence and Molecular Characterization of Extended-Spectrum-β-lactamase (ESBL) and AmpC β-lactamase Genes among Klebsiella spp. and Escherichia coli Colonizing Isolates in Intensive Care Unit Patients. Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, Dallas, Texas, April 2011. 61. Preas, MA, L. Conway, J. Hebden, G. Robinson, M. Lee, J.K. Johnson, K.A. Thom. Investigation of a multi-drug resistant Klebsiella pneumoniae outbreak in a Cardiac Surgery Intensive Care Unit (CSICU). Association for Professionals in Infection Control and Epidemiology (APIC) 2011 Annual Meeting, Baltimore. 62. Harris-Williams M., K.A. Thom, J.K. Johnson, G. Robinson, J. Hebden. Remaining Vigilant in Monitoring for Methicillin- Susceptible Staphylococcus aureus (MSSA) in a Page 28 JKJohnson Neonatal Intensive Care Unit (NICU). Association for Professionals in Infection Control and Epidemiology (APIC) 2011 Annual Meeting, Baltimore. 63. Stancil A., J.P. Furuno, O.C. Stine, L. Zhao, A.D. Harris, R.A. Bonomo, J.K. Johnson. Characterization of Plasmids Among Escherichia coli and Klebsiella spp. Possessing AmpC βlactamases. Interscience Conference on Antimicrobial Agents and Chemotherapy 51st Meeting. September 2011. Chicago, IL. (Abstract # k-1917) 64. Hazen T.H., D.A. Rasko, L. Zhao, A.D. Harris, J.K. Johnson. Similarity of plasmids harboring FOX-5 AmpC -lactamases in Escherichia coli and Klebsiella spp. Interscience Conference on Antimicrobial Agents and Chemotherapy 51st Meeting. September 2011. Chicago, IL. 65. Johnson J.K., G. Robinson, D.J. Morgan, A.D. Harri and the BUGG Network. Survival of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE) for an Extended Period of Transport. Interscience Conference on Antimicrobial Agents and Chemotherapy 51st Meeting. September 2011. Chicago, IL. (Abstract # K-213) 66. Johnson J.K., K.A. Thom, A.D. Harris, D.J. Morgan, A.O. Ajao, J.P. Furuno. Carbapenem Resistance in Extended-spectrum Beta-lactamase (ESBL)-producing Klebsiella and Escherichia coli (ESBL-KE). Interscience Conference on Antimicrobial Agents and Chemotherapy 51st Meeting. September 2011. Chicago, IL. (Abstract # K-818) 67. Comer A.C., J.K. Johnson, J.M. Hirshon, K.K. Hall, S.L. Moore, J.H. Rosenberg, T.D. MacKenzie, J.P. Furuno. Development of Nursing Home-specific Antibiograms. 51st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. September 2011, Chicago IL. 68. Strassle P, Thom K, Johnson J.K., Shanholtz C, Mueller K, Lissauer M, Rew C, Raymond L, Harris AD. Environmental Contamination by Patients with Multidrug-resistant Acinetobacter baumannii. At the 51th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2011. (Poster Presentation) 69. Roghmann M.C., J.K. Johnson, E.F. Mongodin. Metagenomic Analysis of Anterior Nares Colonization in Nursing Home Residents. At the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA. October 20-23, 2011. (Poster Presentation) 70. T. Ranke, M. Lee, G. Robinson, T. Karchmer, J.K. Johnson. Polymerase Chain Reaction (PCR) Based Identification Of VanA And VanB Genes For The Detection Of Vancomycin Resistant Enterococci (VRE) From Rectal Samples In A Long Term Rehabilitation Hospital. American Society of Microbiology 112th General Meeting. June 2012. San Francisco, CA. 71. Smith, M.D. B. Turng. A.D. Harris. A.J. Horneman. J.K. Johnson. Mechanisms of Carbapenem Resistance in Multidrug-Resistant (MDR) Acinetobacter baumannii in Maryland. American Society of Microbiology 112th General Meeting. June 2012. San Francisco, CA. 72. Johnson, J.K., LE Wilson, L. Zhao, K.A. Thom, A.D. Harris, and Maryland MDRO Prevention Collaborative. Assessing the Prevalence of Enterobacteriaceae Producing Klebsiella pneumoniae Carbapenemases (KPC) in Maryland. At the 52th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, September 2012. (Poster Presentation) 73. McDanel JS, Perencevich E, Diekema DJ, Winokur P, Johnson J.K., Schweizer ML. The Molecular Epidemiology of Staphylococcus aureus from Patients with Influenza-Like-Illness (ILI) Who Develop Secondary S. aureus Pneumonia. Poster Presentation. ID Week Conference, A Joint Meeting of Infectious Diseases Society of America, Society for Healthcare Page 29 JKJohnson Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society, San Diego, CA. October 18, 2012. 74. McDanel JS, Perencevich E, Diekema DJ, Storm J, Winokur P, Johnson J.K., Schweizer ML. The Epidemiology of Patients with Post-Influenza S. aureus Pneumonia. Poster Presentation. ID Week Conference, A Joint Meeting of Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society, San Diego, CA. October 19, 2012. 75. Pepin CS, Ranke TD, Harris AD, Pineles L, Morgan DJ, Johnson J.K. The Prevalence of Carbapenem-Resistant Gram-Negative Gastrointestinal Colonization on Admission and Discharge in the ICU in 20 Geographically Different Acute Care Centers in the U.S. At the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Denver, CO, September 2013. (Oral Presentation) 76. Heil E, Boutin M, Johnson J.K. Characterizing Ceftaroline and Daptomycin MICs Compared to Vancomycin MICs in Staphylococcus aureus Blood Culture Isolates at a Large Academic Medical Center. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO. September 2013. 77. Kanack K, Salimnia H, Schreckenberger P, Johnson K., Carroll K, Morgan M, Loeffelholz M, Jenkins S, Daly J, Richards S, Barrett B, Bouzac K, Lingenfelter B. Clinical Evaluation of a Multiplex PCR Blood Culture Identification Panel for Simultaneous Detection of Bacteria, Yeast, and Select Antimicrobial Resistance Genes. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO. September 2013. 78. Papp-Wallace KM, Winkler ML, Gatta JA, Taracila MA, Chilakala S, Xu Y, Johnson J.K., Bonomo RA. Avibactam (AVI) is a Potent Inhibitor of the CMY-2 β-lactamase and Restores the Susceptibility of Ceftaxidime (CAZ) Against CMY-Producing E. coli. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO. September 2013. 79. Boutin M, Ranke T, Harris H, Thom K, Johnson J.K. Increase in Colonization Prevalence of Klebsiella pneumoniae Carbapenemase (KPC) producing Enterobacteriaceae in Intensive Care Units Over a 6-Year Period. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO. September 2013. 80. McDanel JS, Perencevich E, Diekema DJ, Winokur P, Johnson J.K., Herwaldt L, Smith T, Chrischilles E, Dawson J, Schweizer ML. Predictors of Poor Outcomes in Patients with Methicillin-resistant Staphylococcus aureus (MRSA) Pneumonia. ID Week Conference, A Joint Meeting of Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society, San Diego, CA. October 2, 2013. 81. Boutin M, Thom K, Zhan M, Johnson J.K. A novel agent to decrease contamination on hospital scrubs. ID Week Conference, A Joint Meeting of Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society, San Diego, CA. October 2, 2013. 82. Cifra CL, Johnson J.K., Custer JW. Invasive Community-Associated MRSA Infection Presentation as a Lemierre-like Syndrome in an Adolescent Boy. 20th Pediatric Critical Care Colloquium. Washington DC. November 2-5, 2013. 83. Bork JT, Heil E, Leekha S, Johnson J.K. Impact of CLSI Guideline 2014 Changes on the Reporting of Cefepime Susceptibility for Enterobacteriaceae at ICAAC 2014, Washington DC, September 7, 2014. (Poster) Page 30 JKJohnson 84. Heil E, Leekha S, Bork JT, Johnson J.K. Impact of CLSI Enterobacteriaceae Breakpoint Changes on Antibiotic Use at a Large Academic Medical Center at ICAAC 2014, Washington DC, September 7, 2014. (Poster) 85. Roghmann M, Johnson J.K., Sorkin J, Langenberg P, Sorace B and Mody L. Methicillinresistant S. aureus (MRSA) and Methicillin-susceptible S. aureus (MSSA) Transmission to the Gowns and Gloves of Health Care Workers interacting with Long Term Care Residents at ID Week 2014, Philadelphia PA, October 9, 2014. (Poster) 86. Rock C, Harris AD, Johnson J.K., Bischoff W, Thom K. Infrequent Air Contamination with Acinetobacter baumannii Surrounding Known Colonized/Infected patients at ID Week 2014, Philadelphia PA, October 9, 2014. (Poster) 87. Bork JT, Heil E, Leekha S, Badamas R, Johnson J.K.. Rapid Testing using Verigene Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative Bacteremia at ID Week 2014, Philadelphia PA, October 9, 2014. (Poster) 88. Epstien, L, Laufer AS, Preas MA, Harris AD, Johnson J.K., Blythe D, Edwards JR, Gould CV, Leekha S. Successful Interventions to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital, Baltimore, MD, 2011-2013 at ID Week 2014, Philadelphia PA, October 10, 2014. (Oral) 89. Al-Salamah T, Hines MC, Hayes B, Heil E, Witting M, Johnson J.K., Winters M, Gaasch W, Mallemat. Antibiogram does not predict Escherichia coli resistance to ciprofloxacin in women presenting with uncomplicated urinary tract infection to an urban, academic medical center emergency department: a prospective, observational study [Abstract program #254]. 2014 American College of Emergency Physicians Scientific Assembly. Chicago, IL. Ann Emerg Med 2014;64(4 Supplement):S91. 90. Johnson, J.K., G Robinson, N Karikari, L Zhao, T Wagener, T Walker. The Acuitas MDRO Gene Test Compared to Culture/Molecular Assay for Detection of Gene Families Associated with Multidrug-Resistant Organisms from Single Peri-anal Swabs for Surveillance. ECCMID. April 2015. Denmark. 91. Lascols, C, SC Bonaparte, DR Lonsway, J.K. Johnson, G Robinson, JK Rasheed, BM Limbago. Snapshot of Antimicrobial Resistance in Enterobacteriaceae in the United States. ECCMID. April 2015. Denmark. 92. Morgan DJ, CAD Burnham, L Pineles, J.K. Johnson, AD Harris, E Dubberke. The frequency of Clostridium difficile colonization and transmission in an intensive care unti (ICU). Society of Hospital Epidemiology (SHEA) Spring 2015. May 14-17 in Orlando, Florida. Poster 7137. 93. MC Roghmann, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L Mody. Transmission of MRSA to Healthcare Personnel Gowns and Gloves During Care of Nursing Home Residents. Society of Hospital Epidemiology (SHEA) Spring 2015. May 14-17 in Orlando, Florida. Oral 7125. 94. Doll M, MA Preas, C Mitchell, L Wilson, C Carothers, J.K. Johnson, S Leekha. Pseudooutbreak of Aspergillosis at a Tertiary Care Hospital. Society of Hospital Epidemiology (SHEA) Spring 2015. May 14-17 in Orlando, Florida. 95. Robinson, G, N Karikari, T Wagner, T Walker, J.K. Johnson. The Detection of Carbapenemases in Carbapenem-Resistant Gram-Negative Bacteria from an Academic Medical Center. American Society of Microbiology 115th General Meeting. May 2015. New Orleans, LA. Poster 1067. Page 31 JKJohnson 96. A Demogines, S. Fouch, JM Balada-Llasat, K Everhart, A Leber, T Barney, JA Daly, T Burger, P Lephart, S. Desjarlais, P Schreckenberger, C Rells, SL Reed, L LeBlanc, KC Chapin, J.K. Johnson, JA Miller, KC Carroll, J Mestas, J Dien Bard, T Enomoto, MJ Bankowski, K Holmberg, KM Bourzac. Multi-Center Clinical Evaluation of a Multiplex Meningitis/Encephalitis PCR Panel for Simultaneous Detection of Bacteria, Yeast, and Viruses in Cerebrospinal Fluid Specimens. American Society of Microbiology 115th General Meeting. May 2015. New Orleans, LA. Poster 1074. 97. MC Roghmann, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L Mody. Transmission of MRSA to Healthcare Personnel Gowns and Gloves During Care of Nursing Home Residents. American Geriatric Society (AGS) Annual Meeting. May 15-17, 2015 in National Harbor, Maryland. Poster B167, chosen for the Presidential Poster Session. 98. Pineles L, Morgan DJ, Johnson J.K., Sorkin J, Langenberg P, Lydecker A, Lesse A, Sellick J, Gupta K, Leykum L, Lepcha N, Roghmann MC. Gown and glove use to prevent the spread of MRSA in VA Community Living Centers (CLCs). Poster presented at ID Week, October 2015, San Diego, CA. 99. J.K. Johnson, V Albrecht, M Karlsson, GL Robinson, V Stevens, B Werner, A Schuetz, D Wolk, EM Marlowe, E Babady, M Miller, K Culbreath, S Butler-Wu, D Diekema, JK Rasheed, B Limbago. Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in US Clinical Laboratories. ASM Microbe 2016 Meeting on June 20, 2016 in Boston, MA. 100. H Poonawala, K Saharia, S Medino-Moreno, M Filippell, JK Johnson, S Leekha, RR Redfield. Use of a Single Xpert MTB/RIF Assay to Determine Duration of Airborne Isolation in Hospitalized Patients Suspected of Pulmonary Tuberculosis. ID-Week. October 26-20, 2016 New Orleans, LA. (poster accepted) Published Multimedia 1. Nataro, JP, I Stephens, J.K. Johnson. Molecular Diagnosis of Infectious Diseases. Critical Conversations with Pediatric Experts. November 2010. 5(11) Interviewed, “New Test for Detecting Specific Flu Viruses”. Pediatric Press Fall 2010/Winter 2011 University of Maryland Hospital for Children, University of Maryland Medical Center. 2. Interviewed. A Quicker Test for Deadly Viruses in the Very Young. The Baltimore Sun. Monday October 18, 2010. Pages 1 and 5. 3. Interviewed. WJZ TV. Monday October, 18, 2010. News at 5 p.m., 6 p.m., and 11 p.m. 4. Johnson, JK. “A Case of Mistaken Identity” ASM Clinical Microbiology Mentoring Committee Case Report. 2015. http://clinmicro.asm.org/index.php/explore-theprofession/what-is-clinical-microbiology/418-clinical-microbiology-case-studies-clinicalmicrobiology-case-studies Major Invited Speeches Local 1. Johnson, J.K., “Epidemiology of Antibiotic Resistant Gram Negative Organisms.” Medical Technology Research Seminar, Department of Medical Research and Technology, University of Maryland School of Medicine, Baltimore, Maryland, 2009. 2. Johnson, J.K., “Multi-drug Resistant Gram Negative Microorganisms (MDRO)” University of Maryland Medical Center, Laboratories of Pathology, Baltimore, Maryland, 2011. Page 32 JKJohnson 3. 4. 5. 6. 7. 8. 9. 10. Johnson, J.K. “Career Options: Director of a Clinical Microbiology Laboratory” American Society of Microbiology, Maryland Branch on May 3, 2012. Johnson, J.K. “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug. What are they and how to the affect your antimicrobial options.” Department of Medicine Grand Rounds, Maryland General Hospital, Baltimore, Maryland on May 9, 2013. Keynote Address at Pre-commencement ceremony. Department of Medical and Research Technology at the University of Maryland, Baltimore on May 17, 2012. Johnson, J.K. “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug.” Clinical Didactic Conference. Department of Medical and Research Technology University of Maryland School of Medicine, Baltimore, Maryland on May 30, 2013. Johnson, J.K. “Detecting Drug Resistance in Gram-negative Bacteria” Novel Aspects in Biomedical Sciences Series, Department of Medical and Research Technology University of Maryland School of Medicine, Baltimore, Maryland on September 24, 2013. Johnson, J.K. “Multidrug-Resistant Organisms (MDROs): The Gram Negative Perspective” New Molecular Screening Solutions for Multi-Drug Resistant Organisms, OpGen, November 22, 2013. Johnson, J.K. “Transmission of Emerging Plasmid-mediated β-lactamases in Multi-drug Resistant Gram-negative Bacteria” Department of Microbiology and Immunology Seminar, University of Maryland School of Medicine, Baltimore, Maryland on March 5, 2014. Johnson, J.K. “Transmission of Multi-drug Resistant Gram-negative Bacteria” Mesoscale Diagnostics, Rockville, Maryland on April 23, 2014. National 1. Johnson, J.K. “Antibiotic Resistance in Gram Negative Bacteria – Focus on βlactamases,” 24th Annual Maryland Clinical Microbiology Meeting, Annapolis, Maryland 2007. 2. Johnson, J.K. “Impact of Rapid C. albicans, S. aureus, and Enterococcus Results on Patient Care” Educational Seminar, 107th American Society of Microbiology General Meeting, Toronto, Ontario, Canada, 2007. 3. Johnson, J.K., “The Role of the Microbiologist in Infection Control” 11th Annual Infectious Disease Fellows Course on Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, 2007. 4. Johnson, J.K. “Rapid and Real-time Rapid Diagnostic from Positive Blood Cultures: The UMMC Experience” Northeastern Ohio Association of Clinical Microbiologists, Cleveland, Ohio, 2008. 5. Johnson, J.K., “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug.” Department of Medicine Grand Rounds, Geisinger Medical Center, Danville, Pennsylvania on September 6, 2013. 6. Johnson, J.K. “Multi-drug Resistant Organisms (MDROs): The Threat We Face.” ASM Satellite Symposium. 114th General Meeting American Society of Microbiology. Boston, Massachusetts. May 19, 2014. Page 33 JKJohnson 7. 8. 9. 10. 11. Johnson, J.K., “The Role of the Microbiologist in Infection Control and Hospital Epidemiology” at the 18th Annual Infectious Disease Fellows Course on Infectious Diseases at Johns Hopkins University on July 8, 2014 in Baltimore, Maryland. Johnson, JK. “The Impact of Rapid Molecular Analysis of Positive Blood Cultures: Discovering the antimicrobial Stewardship Dream Team” at the Pathology Grand Rounds at Cornell-Weill Medical College on April 1, 2015. “What to Report to Clinicians to Reduce Unnecessary Treatment-Explaining Clinical Microbiology Reports/Providing Limited Information.” at the 115th General Meeting of the American Society of Microbiology in the Diagnostic Microbiology and Epidemiology Symposium, Session Titled Overuse and Overdiagnosis in Clinical Microbiology on June 1, 2015 in New Orleans, LA. Johnson, J.K. “Guess the Resistance Mechanism-Case 1” at the ASM Microbe 2016 Meeting of the American Society of Microbiology in the Clinical Science and Epidemiology Symposium, Session Titled Guess the Resistance Mechanism on June 18, 2016 in Boston, MA. Johnson, J.K. “Guess the Resistance Mechanism-Case 2” at the ASM Microbe 2016 Meeting of the American Society of Microbiology in the Clinical Science and Epidemiology Symposium, Session Titled Guess the Resistance Mechanism on June 18, 2016 in Boston, MA International 1. Johnson, J.K. “Healthcare Associated Infections (HAIs): The Role of the Microbiology Laboratory.” Puerto Rico Society of Microbiologist and Puerto Rico ASM Branch SemiAnnual Meeting New Trends and Diagnostic Challenges in Healthcare Associated Infections (HAIs), Guaynabo, Puerto Rico on January 25, 2014. Page 34